What is Enzyme (MLN)?

Deep Dive

1. Purpose & Value Proposition

Enzyme aims to decentralize and streamline asset management. It acts as core infrastructure for "tokenized finance," allowing fund managers to launch and operate investment vehicles—known as vaults—that can hold cryptocurrencies, real-world assets (RWAs), and other instruments. This solves the problem of opaque, manual traditional finance by bringing the entire lifecycle of a fund on-chain, enabling transparency, automation, and accessibility for both institutional and individual investors (Enzyme Documentation).

2. Technology & Architecture

Built primarily on Ethereum, Enzyme functions as a set of smart contracts that automate fund administration. Users can create a vault and define its investment strategy, which the protocol then executes autonomously across various DeFi protocols. Key products like Onyx (a vault-as-a-service tech stack) and Myso (an on-chain options protocol) showcase its modular, "plug-and-play" architecture designed for security and cross-chain functionality.

3. Tokenomics & Governance

The MLN token is the utility and governance key for the network. Users must pay fees in MLN to access the protocol, calculated as 0.25% of the assets under management (AUM) linked to their vault. These paid MLN tokens are automatically burned, creating a deflationary pressure. Governance is managed by the Enzyme Council DAO, which can adjust parameters and allocate up to 300,600 new MLN minted annually for ecosystem development and grants (Enzyme Documentation).

Conclusion

Enzyme is fundamentally a permissionless infrastructure layer for building and accessing tokenized financial products. Its success is tied to the growth of on-chain asset management. Will its modular design become the standard framework for next-generation funds?